Towards personalized tumor markers
Abstract The cancer biomarker discovery pipeline is progressing slowly. The difficulties of finding novel and effective biomarkers for diagnosis and management of cancer patients are well-known. We speculate that it is unlikely to discover new serological biomarkers characterized by high sensitivity...
Guardado en:
Autores principales: | Vathany Kulasingam, Ioannis Prassas, Eleftherios P. Diamandis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e17bc80beb4f4e19b16255e97dc4774b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
por: Ugljesa Djuric, et al.
Publicado: (2017) -
Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
por: Ruining Gong, et al.
Publicado: (2021) -
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
por: Yan W. Asmann, et al.
Publicado: (2021) -
Precision oncology- the future of personalized cancer medicine?
por: Ann M. Bode, et al.
Publicado: (2017) -
Panels and models for accurate prediction of tumor mutation burden in tumor samples
por: Elizabeth Martínez-Pérez, et al.
Publicado: (2021)